JYSB2500026 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB1600273 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-01-03 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2017-04-10 | view |
CYSB2400087 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2024-04-09 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
JYSB1900085 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-04-24 | | Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2019-10-30 | view |
CYSB2200011 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2022-01-10 | | SinoCelltech Ltd | | | view |
JYSZ1600015 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2016-05-10 | | Baxter AG;Baxalta Manufacturing Sàrl | Certificate Issued | 2017-04-19 | view |
JYSZ1800031 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2018-07-20 | | Bayer Healthcare LLC | Certificate Issued | 2019-06-03 | view |
JYSB1700078 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-05-03 | | Bayer Healthcare LLC | Certificate Issued | 2018-06-15 | view |
JYSB2200143 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
JYSB2101028 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-05-12 | | Bayer Healthcare LLC | | | view |
JYSB1800189 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-10 | | Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2019-02-02 | view |
JYSB1800050 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-23 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
JYSB1900275 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-09-28 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Certificate Issued | 2019-10-28 | view |
CYSB2200010 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2022-01-10 | | SinoCelltech Ltd | | | view |
JYSB1800221 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-10-25 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2018-12-17 | view |
JYSB2200065 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-04-08 | | Novo Nordisk A/S | | | view |
JYSB1800112 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-05-17 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2018-05-30 | view |
JYSZ1700006 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2017-03-06 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2018-07-18 | view |
JYSB1900286 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-11-22 | | Baxter AG;Baxalta Manufacturing Sàrl | Certificate Issued | 2020-01-03 | view |
JYSB2400156 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-07-16 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |